Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

Video Expert Opinion

Colleague Insights

Conferences

Published in Multiple Sclerosis and

Journal Scan / Research · May 02, 2022

Economic Burden of MS in the US

Neurology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Michael Kornberg MD, PhD

Neurology

Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs

Neurology 2022 Apr 13;[EPub Ahead of Print], B Bebo, I Cintina, N LaRocca, L Ritter, B Talente, D Hartung, S Ngorsuraches, M Wallin, G Yang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Multiple Sclerosis

Economic Burden of MS in the US

Additional Info

Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs

Further Reading

Hypogammaglobulinemia and Severe Infections in Patients With MS on Anti-CD20 Agents

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma

Association of the Cervical Canal Area With Disability and Progression in People With MS

Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma

2024 Top Story in Neurology: Management and Diagnosis of Multiple Sclerosis

Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma

Increased Disability Progression in rs10191329AA Carriers With MS Is Preceded by Neurofilament Light Chain Level Elevations

Neurologic Outcomes in People With MS Treated With Immune Checkpoint Inhibitors for Oncologic Indications

Cannabinoids for Spasticity in Patients With MS

The Presence of Oligoclonal Bands Predicts Conversion to MS in Patients With Isolated Myelitis

Efficacy and Safety of an Ocrelizumab Biosimilar vs the Originator Product in Patients With Relapsing MS

Recently Updated